An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells
Crossref DOI link: https://doi.org/10.1007/s11427-016-5035-4
Published Online: 2016-03-24
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Yajing
Zhang, Wenying
Dai, Hanren
Wang, Yao
Shi, Fengxia
Wang, Chunmeng
Guo, Yelei
Liu, Yang
Chen, Meixia
Feng, Kaichao
Zhang, Yan
Liu, Chuanjie
Yang, Qingming
Li, Suxia
Han, Weidong